The University of Oregon's deal with Nike could become even sweeter. The program could reportedly get more than $88 Million in cash, apparel, and shoes over an 11-year contract. StockX CEO Josh Luber explains what this means for the athletic retailer, and college athletics.
Luber says this potential deal between University of Oregon and Nike is not that major in the bigger picture of college athletics. But when looking at the downstream impact on retail, it means Nike will continue to make interesting gear that gets sold at both the retail and resale level.
Luber also shares the hottest sneakers on the resale market this week. The Yeezy 350 Boost Beluga 2.0 dropped on November 25, and now the sneakers are reselling at nearly double its retail price. Compared to other Yeezy's, this product has more supply.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
Tesla is reportedly moving forward with its plan to make energy shortage storage batteries in China.
Wells Fargo employees at a branch in New Mexico have voted to unionize.
Nike cut its full-year revenue outlook for the fiscal year after reporting lower-than-expected revenue in its latest quarter.
